Dr. Lawrence Newman: “Too Many Patients with Migraine Receiving Opioids, Barbiturates”
Inappropriate prescribing of opioids and barbiturates for the treatment of migraine is common, a new study suggests. Also surprising was the duration for which many patients had been receiving the medications, with a quarter reporting having been taking them for more than two years. Asked to comment, American Headache Society President Lawrence C. Newman, MD, told Medscape Medical News that the study "both surprises and dismays me." Dr. Newman, a professor of neurology at the Icahn School of Medicine at Mount Sinai and Director of The Headache Institute at Mount Sinai Roosevelt, said, "We've known for years that the use of opioids and barbiturates is inappropriate for patients who suffer from migraine for a number of reasons, not the least of which is that they induce more frequent headaches if taken in excess." Learn more
Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
Mar 02, 2023 View All Press Releases
Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain
Nov 30, 2022 View All Press Releases
